Products - Chronic obstructive pulmonary disease | Topic | NICE

Showing 5 products

Date | Title

Status: In developmentRemove ‘Status: In development’ filter

Mepolizumab for maintenance treatment of uncontrolled chronic obstructive pulmonary disease with raised blood eosinophils ID1237
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
6 August 2026
Dupilumab for maintenance treatment of uncontrolled chronic obstructive pulmonary disease with raised blood eosinophils ID6235
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Astegolimab as add-on maintenance treatment for moderate to severe chronic obstructive pulmonary disease [ID6524]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Itepekimab as add-on maintenance treatment for moderate to severe chronic obstructive pulmonary disease [ID6547]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Benralizumab to reduce exacerbations in moderate to very severe chronic obstructive pulmonary disease [ID1394]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC